enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVNO is expected to report earnings to fall 56.24% to -234 cents per share on March 04
Q4'26
Est.
$-2.35
Q2'26
Missed
by $5.11
Q1'26
Missed
by $5.65
Q4'25
Missed
by $5.77
Q3'25
Beat
by $0.07
The last earnings report on July 31 showed earnings per share of -536 cents, missing the estimate of -25 cents. With 5.80K shares outstanding, the current market capitalization sits at 5.09M.